Literature DB >> 2043649

Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.

R J Turner1, J M Matsoukas, G J Moore.   

Abstract

Nanosecond time-resolved decays from excited-state tyrosinate fluorescence of angiotensin II analogues were measured from the emission at 350 nm. Fluorescence lifetimes were determined in several different solvents using N-acetyltyrosinamide as the reference standard. Long-lifetime tyrosinate fluorescence (LTF) of angiotensin II (ANG II) was observed in propylene glycol, trifluoroethanol and isopropanol but not in DMSO or water. The addition of SDS at a concentration sufficient to induce micelle formation in water resulted in LTF for ANG II. LTF for ANG II was longer in propylene glycol (21 ns) than in isopropanol (16 ns) whereas the % conformer(s) producing LTF was higher in isopropanol (79%) than in propylene glycol (19%). For a series of ten angiotensin analogues, LTF values determined in propylene glycol and isopropanol were a reflection of the contractile activities of these analogues in the rat uterus assay. In propylene glycol, with the notable exception of ANG III, biologically active analogues had longer LTFs (13-21 ns) than inactive analogues (0-11 ns). In isopropanol, strong agonists had longer LTFs (13-16 ns) than weak agonists/inactive analogues (0-11 ns). Structure-fluorescence relationships suggest that the primary TyrOH acceptor in ANG II is the His6 imidazole group, and that the C-terminal carboxylate has an essential auxiliary role in generating long-lived tyrosinate fluorescence. The present findings appear to support the proposition that the receptor conformation of ANG II contains a tripartite interaction of Tyr, His and carboxylate groups which is analogous to that found at the active site of serine proteinases, and that the tyrosinate nucleophile may activate angiotensin receptors. Solvents of intermediate polarity such as propylene glycol and isopropanol appear to induce conformations for small peptides such as angiotensin which resemble those present at membrane receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043649     DOI: 10.1016/0005-2736(91)90005-s

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies.

Authors:  George Agelis; Panagiota Roumelioti; Amalia Resvani; Serdar Durdagi; Maria-Eleni Androutsou; Konstantinos Kelaidonis; Demetrios Vlahakos; Thomas Mavromoustakos; John Matsoukas
Journal:  J Comput Aided Mol Des       Date:  2010-07-10       Impact factor: 3.686

2.  Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor.

Authors:  K Prendergast; K Adams; W J Greenlee; R B Nachbar; A A Patchett; D J Underwood
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

3.  The tyrosyl fluorescence of angiotensin II in alcoholic solvents.

Authors:  K J Willis; A G Szabo
Journal:  J Fluoresc       Date:  1992-03       Impact factor: 2.217

Review 4.  A Global Review on Short Peptides: Frontiers and Perspectives.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Tsun-Thai Chai; Sherif Elnagdy; Krzysztof Kaczmarek; John Matsoukas; Roger New; Keykavous Parang; Octavio Paredes Lopez; Hamideh Parhiz; Conrad O Perera; Monica Pickholz; Milan Remko; Michele Saviano; Mariusz Skwarczynski; Yefeng Tang; Wojciech M Wolf; Taku Yoshiya; Janusz Zabrocki; Piotr Zielenkiewicz; Maha AlKhazindar; Vanessa Barriga; Konstantinos Kelaidonis; Elham Mousavinezhad Sarasia; Istvan Toth
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 5.  From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.

Authors:  John Matsoukas; Vasso Apostolopoulos; Anthony Zulli; Graham Moore; Konstantinos Kelaidonis; Kalliopi Moschovou; Thomas Mavromoustakos
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

6.  Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  John M Matsoukas; Laura Kate Gadanec; Anthony Zulli; Vasso Apostolopoulos; Konstantinos Kelaidonis; Irene Ligielli; Kalliopi Moschovou; Nikitas Georgiou; Panagiotis Plotas; Christos T Chasapis; Graham Moore; Harry Ridgway; Thomas Mavromoustakos
Journal:  Biomedicines       Date:  2022-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.